Research Objective: Improving Alzheimer’s treatment protocols in patients, going beyond mono-therapy medicines, and following the latest coordinated multi-faceted systems approaches that have been recently published by UCLA’s renown neurodegenerative expert Dr. Dale Bredesen, MD, of the UCLA Mary S. Easton Center for Alzheimer’s Disease Research and the Buck Institute for Research on Aging. Patient: Dr. David … Continue reading Alzheimer’s Disease + Our founding mentor’s condition